JACOBS IAN SETH (President, Sec., CEO, and CFO) reported 1 transaction at TRANSPHORM, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/14/2020ACC: 0001213900-20-004042
DirectorOfficer· President, Sec., CEO, and CFO
Since Oct 2017
-25K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
25K disposed
Non-Derivative Transactions1
Common Stock, par value $0.0001
Direct
Shares
−25K
Price / share
—
Trade value
—
% of position
16.7%
2/12/2020
150K→125K
Total
Net shares
−25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 Direct | 2/12/2020 | J · J | −25K | — | — | 16.7% | 150K | 125K |
| Total | −25K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported